Cargando…

Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver

Many frequently prescribed drugs are non-genotoxic carcinogens (NGC) in rodent liver. Their mode of action and health risks for humans remain to be elucidated. Here, we investigated the impact of two model NGC, the anti-epileptic drug phenobarbital (PB) and the contraceptive cyproterone acetate (CPA...

Descripción completa

Detalles Bibliográficos
Autores principales: Nejabat, Marzieh, Riegler, Teresa, Reitinger, Tabea, Subosits, Sandra, Römer, Michael, Eichner, Johannes, Bilban, Martin, Zell, Andreas, Huber, Wolfgang W., Schulte-Hermann, Rolf, Grasl-Kraupp, Bettina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818586/
https://www.ncbi.nlm.nih.gov/pubmed/29270806
http://dx.doi.org/10.1007/s00204-017-2080-0
_version_ 1783301054161485824
author Nejabat, Marzieh
Riegler, Teresa
Reitinger, Tabea
Subosits, Sandra
Römer, Michael
Eichner, Johannes
Bilban, Martin
Zell, Andreas
Huber, Wolfgang W.
Schulte-Hermann, Rolf
Grasl-Kraupp, Bettina
author_facet Nejabat, Marzieh
Riegler, Teresa
Reitinger, Tabea
Subosits, Sandra
Römer, Michael
Eichner, Johannes
Bilban, Martin
Zell, Andreas
Huber, Wolfgang W.
Schulte-Hermann, Rolf
Grasl-Kraupp, Bettina
author_sort Nejabat, Marzieh
collection PubMed
description Many frequently prescribed drugs are non-genotoxic carcinogens (NGC) in rodent liver. Their mode of action and health risks for humans remain to be elucidated. Here, we investigated the impact of two model NGC, the anti-epileptic drug phenobarbital (PB) and the contraceptive cyproterone acetate (CPA), on intrahepatic epithelial–mesenchymal crosstalk and on growth of first stages of hepatocarcinogenesis. Unaltered hepatocytes (HC) and preneoplastic HC (HC(PREN)) were isolated from rat liver for primary culture. DNA replication of HC and HC(PREN) was increased by in vitro treatment with 10 µM CPA, but not 1 mM PB. Next, mesenchymal cells (MC) obtained from liver of rats treated with either PB (50 mg/kg bw/day) or CPA (100 mg/kg bw/day), were cultured. Supernatants from both types of MC raised DNA synthesis of HC and HC(PREN). This indicates that PB induces replication of HC and HC(PREN) only indirectly, via growth factors secreted by MC. CPA, however, acts on HC and HC(PREN) directly as well as indirectly via mesenchymal factors. Transcriptomics and bio-informatics revealed that PB and CPA induce extensive changes in the expression profile of MC affecting many growth factors and pathways. MC from PB-treated rats produced and secreted enhanced levels of HBEGF and GDF15, factors found to suppress apoptosis and/or induce DNA synthesis in cultured HC and HC(PREN). MC from CPA-treated animals showed enhanced expression and secretion of HGF, which strongly raised DNA replication of HC and HC(PREN). In conclusion, our findings reveal profound effects of two prototypical NGC on the hepatic mesenchyme. The resulting release of factors, which suppress apoptosis and/or enhance cell replication preferentially in cancer prestages, appears to be crucial for tumor promotion by NGC in the liver. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-017-2080-0) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-5818586
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-58185862018-02-27 Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver Nejabat, Marzieh Riegler, Teresa Reitinger, Tabea Subosits, Sandra Römer, Michael Eichner, Johannes Bilban, Martin Zell, Andreas Huber, Wolfgang W. Schulte-Hermann, Rolf Grasl-Kraupp, Bettina Arch Toxicol Genotoxicity and Carcinogenicity Many frequently prescribed drugs are non-genotoxic carcinogens (NGC) in rodent liver. Their mode of action and health risks for humans remain to be elucidated. Here, we investigated the impact of two model NGC, the anti-epileptic drug phenobarbital (PB) and the contraceptive cyproterone acetate (CPA), on intrahepatic epithelial–mesenchymal crosstalk and on growth of first stages of hepatocarcinogenesis. Unaltered hepatocytes (HC) and preneoplastic HC (HC(PREN)) were isolated from rat liver for primary culture. DNA replication of HC and HC(PREN) was increased by in vitro treatment with 10 µM CPA, but not 1 mM PB. Next, mesenchymal cells (MC) obtained from liver of rats treated with either PB (50 mg/kg bw/day) or CPA (100 mg/kg bw/day), were cultured. Supernatants from both types of MC raised DNA synthesis of HC and HC(PREN). This indicates that PB induces replication of HC and HC(PREN) only indirectly, via growth factors secreted by MC. CPA, however, acts on HC and HC(PREN) directly as well as indirectly via mesenchymal factors. Transcriptomics and bio-informatics revealed that PB and CPA induce extensive changes in the expression profile of MC affecting many growth factors and pathways. MC from PB-treated rats produced and secreted enhanced levels of HBEGF and GDF15, factors found to suppress apoptosis and/or induce DNA synthesis in cultured HC and HC(PREN). MC from CPA-treated animals showed enhanced expression and secretion of HGF, which strongly raised DNA replication of HC and HC(PREN). In conclusion, our findings reveal profound effects of two prototypical NGC on the hepatic mesenchyme. The resulting release of factors, which suppress apoptosis and/or enhance cell replication preferentially in cancer prestages, appears to be crucial for tumor promotion by NGC in the liver. ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (doi:10.1007/s00204-017-2080-0) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2017-12-21 2018 /pmc/articles/PMC5818586/ /pubmed/29270806 http://dx.doi.org/10.1007/s00204-017-2080-0 Text en © The Author(s) 2017 Open AccessThis article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.
spellingShingle Genotoxicity and Carcinogenicity
Nejabat, Marzieh
Riegler, Teresa
Reitinger, Tabea
Subosits, Sandra
Römer, Michael
Eichner, Johannes
Bilban, Martin
Zell, Andreas
Huber, Wolfgang W.
Schulte-Hermann, Rolf
Grasl-Kraupp, Bettina
Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title_full Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title_fullStr Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title_full_unstemmed Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title_short Mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
title_sort mesenchyme-derived factors enhance preneoplastic growth by non-genotoxic carcinogens in rat liver
topic Genotoxicity and Carcinogenicity
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5818586/
https://www.ncbi.nlm.nih.gov/pubmed/29270806
http://dx.doi.org/10.1007/s00204-017-2080-0
work_keys_str_mv AT nejabatmarzieh mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT rieglerteresa mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT reitingertabea mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT subositssandra mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT romermichael mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT eichnerjohannes mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT bilbanmartin mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT zellandreas mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT huberwolfgangw mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT schultehermannrolf mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver
AT graslkrauppbettina mesenchymederivedfactorsenhancepreneoplasticgrowthbynongenotoxiccarcinogensinratliver